Core Laboratories Statistics
Total Valuation
CLB has a market cap or net worth of $473.76 million. The enterprise value is $616.14 million.
| Market Cap | 473.76M |
| Enterprise Value | 616.14M |
Important Dates
The next confirmed earnings date is Wednesday, October 28, 2026, after market close.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Aug 10, 2026 |
Share Statistics
CLB has 45.88 million shares outstanding. The number of shares has decreased by -1.80% in one year.
| Current Share Class | 45.88M |
| Shares Outstanding | 45.88M |
| Shares Change (YoY) | -1.80% |
| Shares Change (QoQ) | +1.75% |
| Owned by Insiders (%) | 1.40% |
| Owned by Institutions (%) | 108.38% |
| Float | 45.23M |
Valuation Ratios
The trailing PE ratio is 19.05 and the forward PE ratio is 15.50.
| PE Ratio | 19.05 |
| Forward PE | 15.50 |
| PS Ratio | 0.88 |
| Forward PS | 0.87 |
| PB Ratio | 1.67 |
| P/TBV Ratio | 2.84 |
| P/FCF Ratio | 41.83 |
| P/OCF Ratio | 16.13 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.46, with an EV/FCF ratio of 54.92.
| EV / Earnings | 24.54 |
| EV / Sales | 1.15 |
| EV / EBITDA | 10.46 |
| EV / EBIT | 14.13 |
| EV / FCF | 54.92 |
Financial Position
The company has a current ratio of 2.12, with a Debt / Equity ratio of 0.59.
| Current Ratio | 2.12 |
| Quick Ratio | 1.37 |
| Debt / Equity | 0.59 |
| Debt / EBITDA | 2.12 |
| Debt / FCF | 15.17 |
| Interest Coverage | 3.85 |
Financial Efficiency
Return on equity (ROE) is 9.05% and return on invested capital (ROIC) is 6.75%.
| Return on Equity (ROE) | 9.05% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | 6.75% |
| Return on Capital Employed (ROCE) | 8.70% |
| Weighted Average Cost of Capital (WACC) | 8.91% |
| Revenue Per Employee | $157,328 |
| Profits Per Employee | $7,380 |
| Employee Count | 3,300 |
| Asset Turnover | 0.87 |
| Inventory Turnover | 7.10 |
Taxes
In the past 12 months, CLB has paid $12.10 million in taxes.
| Income Tax | 12.10M |
| Effective Tax Rate | 32.89% |
Stock Price Statistics
The stock price has decreased by -21.14% in the last 52 weeks. The beta is 1.14, so CLB's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | -21.14% |
| 50-Day Moving Average | 11.58 |
| 200-Day Moving Average | 14.58 |
| Relative Strength Index (RSI) | 25.14 |
| Average Volume (20 Days) | 580,638 |
Short Selling Information
The latest short interest is 4.38 million, so 9.55% of the outstanding shares have been sold short.
| Short Interest | 4.38M |
| Short Previous Month | 4.26M |
| Short % of Shares Out | 9.55% |
| Short % of Float | 9.69% |
| Short Ratio (days to cover) | 10.25 |
Income Statement
In the last 12 months, CLB had revenue of $519.18 million and earned $24.35 million in profits. Earnings per share was $0.52.
| Revenue | 519.18M |
| Gross Profit | 101.32M |
| Operating Income | 42.28M |
| Pretax Income | 36.80M |
| Net Income | 24.35M |
| EBITDA | 57.13M |
| EBIT | 42.28M |
| Earnings Per Share (EPS) | $0.52 |
Balance Sheet
The company has $22.74 million in cash and $165.12 million in debt, with a net cash position of -$142.38 million or -$3.10 per share.
| Cash & Cash Equivalents | 22.74M |
| Total Debt | 165.12M |
| Net Cash | -142.38M |
| Net Cash Per Share | -$3.10 |
| Equity (Book Value) | 278.77M |
| Book Value Per Share | 5.94 |
| Working Capital | 113.31M |
Cash Flow
In the last 12 months, operating cash flow was $28.22 million and capital expenditures -$17.34 million, giving a free cash flow of $10.88 million.
| Operating Cash Flow | 28.22M |
| Capital Expenditures | -17.34M |
| Depreciation & Amortization | 14.85M |
| Net Borrowing | -9.63M |
| Free Cash Flow | 10.88M |
| FCF Per Share | $0.24 |
Margins
Gross margin is 19.52%, with operating and profit margins of 8.14% and 4.69%.
| Gross Margin | 19.52% |
| Operating Margin | 8.14% |
| Pretax Margin | 7.09% |
| Profit Margin | 4.69% |
| EBITDA Margin | 11.00% |
| EBIT Margin | 8.14% |
| FCF Margin | 2.10% |
Dividends & Yields
This stock pays an annual dividend of $0.04, which amounts to a dividend yield of 0.40%.
| Dividend Per Share | $0.04 |
| Dividend Yield | 0.40% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 7.68% |
| FCF Payout Ratio | 16.87% |
| Buyback Yield | 1.80% |
| Shareholder Yield | 2.21% |
| Earnings Yield | 5.35% |
| FCF Yield | 2.39% |
Analyst Forecast
The average price target for CLB is $15.00, which is 45.28% higher than the current price. The consensus rating is "Buy".
| Price Target | $15.00 |
| Price Target Difference | 45.28% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 4.91% |
| EPS Growth Forecast (3Y) | 21.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 9, 2010. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 9, 2010 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
CLB has an Altman Z-Score of 3.1 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.1 |
| Piotroski F-Score | 6 |